Cargando…
CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function
CD52, a glycophosphatidylinositol (GPI)-anchored glycoprotein, is released in a soluble form following T cell activation and binds to the Siglec (sialic acid-binding Ig-like lectin)-10 receptor on T cells to suppress their function. We show that binding of CD52-Fc to Siglec-10 and T cell suppression...
Autores principales: | Bandala-Sanchez, Esther, G. Bediaga, Naiara, Goddard-Borger, Ethan D., Ngui, Katrina, Naselli, Gaetano, Stone, Natalie L., Neale, Alana M., Pearce, Lesley A., Wardak, Ahmad, Czabotar, Peter, Haselhorst, Thomas, Maggioni, Andrea, Hartley-Tassell, Lauren A., Adams, Timothy E., Harrison, Leonard C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065011/ https://www.ncbi.nlm.nih.gov/pubmed/29997173 http://dx.doi.org/10.1073/pnas.1722056115 |
Ejemplares similares
-
Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins
por: O’Sullivan, Jeremy A., et al.
Publicado: (2017) -
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
por: Smith, Benjamin A. H., et al.
Publicado: (2021) -
Terminal Epitope-Dependent Branch Preference of Siglecs Toward N-Glycans
por: Wang, Shuaishuai, et al.
Publicado: (2021) -
Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
por: Yu, Yingyan, et al.
Publicado: (2023) -
A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands
por: Rodrigues, Emily, et al.
Publicado: (2020)